Our Mission:
We will improve surgical outcome in patients undergoing high-risk surgeries by reducing post-operative neurological damage, thereby decreasing short- and long-term health care costs and improving quality of life for patients.

The Next Generation of Monitoring Devices

NeuroVascular Research and Design will be the first to automate Intraoperative Monitoring (IOM) which will provide real-time and direct feedback to surgeons regarding potential damage to nerve and vascular structures during surgeries.

 

Automation of Intraoperative Monitoring will:

•Improve surgical outcomes by improving monitoring reliability

•Greatly reduce the cost of IOM and increase its availability, which will allow more surgeries to be monitored

 

History of Intraoperative Monitoring

Current Standard of Care

Over 30 years ago, Neurovascular Research and Design’s CEO and founder, Jeffrey Owen, Ph.D. was one of the original developers of IOM and greatly contributed to the growth of this subspecialty. The work that was developed is still the standard of care for Intraoperative Monitoring. The current standard is a proven, widely adopted methodology for avoiding nerve damage during high risk surgeries.

 

Too Many Patients are Still at Risk

Current IOM methodology is expensive and underutilized; it requires a technician to administer and a physician to monitor. Due to its high costs and limited availability, it is performed in less than 40% of the more than 2 million high-risk surgeries in the US alone, leaving far too many patients at great risk for poor post-surgical outcome such as paralysis, stroke, incontinence, etc. These poor outcomes also leave the health care system vulnerable to unnecessary litigation and cause insurance companies and families burdensome and unnecessary expense.